3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Myelodysplastic Syndromes
40
Leukemia, Myeloid, Acute
40
Leukemia
31
Precursor Cell Lymphoblastic Leukemia-Lymphoma
29
Lymphoma, Non-Hodgkin
26
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
25
Leukemia, Lymphocytic, Chronic, B-Cell
23
Lymphoma
22
Hodgkin Disease
22
Hematologic Neoplasms
22
Multiple Myeloma
18
Myeloproliferative Disorders
13
Graft vs Host Disease
13
Primary Myelofibrosis
12
Leukemia, Myelomonocytic, Juvenile
10
Lymphoma, Mantle-Cell
9
Lymphoma, Large B-Cell, Diffuse
9
Lymphoma, Follicular
8
Lymphoma, B-Cell, Marginal Zone
8
Leukemia, Myelomonocytic, Chronic
7
Lymphoma, Large-Cell, Immunoblastic
6
Leukemia, Myeloid, Accelerated Phase
6
Congenital Abnormalities
6
Burkitt Lymphoma
6
Waldenstrom Macroglobulinemia
5
Neuroblastoma
5
Neoplasms
5
Lymphoma, T-Cell, Cutaneous
5
Leukemia, Myeloid, Chronic-Phase
5
Blast Crisis
5
Interventions
Cyclophosphamide
10
fludarabine
7
Rituximab
6
Bendamustine Hydrochloride
5
venetoclax
4
obinutuzumab
4
Lenalidomide
4
ofatumumab
3
ibrutinib
3
fludarabine phosphate
3
acalabrutinib
3
Vincristine
3
Immunotherapy, Adoptive
3
pirtobrutinib
2
Bortezomib
2
Alemtuzumab
2
zanubrutinib
1
thymoglobulin
1
tenofovir alafenamide
1
ricolinostat
1
pembrolizumab
1
pegaspargase
1
nelarabine
1
idelalisib
1
blinatumomab
1
Whole-Body Irradiation
1
Prednisolone
1
Pentostatin
1
Panobinostat
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Leukemia, B-Cell
×
thymoglobulin
×
Clear all
NCT03852407
2022-10-12
HLA
University of Liege
Phase 2
Recruiting
114 enrolled